MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$66,550K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the exercise of co...
Non-cash stock-based compensatio...
Accrued expenses and other curre...
Others
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other asset...
Operating lease liabilities
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Net loss
-18,012
-7,658
-6,791
-12,414
Non-cash stock-based compensation
1,813
447
503
1,006
Non-cash lease expense
307
154
147
296
Prepaid expenses and other assets
740
-1,090
635
1,423
Accounts payable
138
660
-1,031
-164
Accrued expenses and other current liabilities
378
545
897
-3,383
Operating lease liabilities
-318
-159
-158
-318
Net cash used in operating activities
-16,434
-4,921
-7,068
-16,400
Proceeds from warrant inducements, net of issuance costs
-
29,015
22,027
-
Proceeds from the exercise of common stock warrants
82,918
3,906
4,000
4,712
Proceeds from issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs
0
0
0
23,051
Proceeds from employee stock purchases
66
0
64
48
Tax withholding on vesting of restricted stock units
-
527
-
-
Net cash provided by financing activities
82,984
32,394
26,091
27,811
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents
66,550
27,473
19,023
11,411
Cash, cash equivalents, restricted cash, and restricted cash equivalents at the beginning of period
71,893
44,420
13,986
-
Cash, cash equivalents, restricted cash, and restricted cash equivalents at the end of period
138,443
71,893
44,420
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
exercise of common stock...
$82,918K
(1659.72%↑ Y/Y)
Proceeds from employee
stock purchases
$66K
(37.50%↑ Y/Y)
Net cash provided by
financing activities
$82,984K
(198.39%↑ Y/Y)
Net increase in
cash, cash...
$66,550K
(483.21%↑ Y/Y)
Canceled cashflow
$16,434K
Non-cash stock-based
compensation
$1,813K
(80.22%↑ Y/Y)
Accrued expenses and
other current...
$378K
(111.17%↑ Y/Y)
Non-cash lease expense
$307K
(3.72%↑ Y/Y)
Accounts payable
$138K
(184.15%↑ Y/Y)
Net cash used in
operating activities
-$16,434K
(-0.21%↓ Y/Y)
Canceled cashflow
$2,636K
Net loss
-$18,012K
(-45.09%↓ Y/Y)
Prepaid expenses and
other assets
$740K
(-48.00%↓ Y/Y)
Operating lease
liabilities
-$318K
(0.00%↑ Y/Y)
Buy us a coffee
SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group, Inc. (SLS)